| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-07 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-07 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.0008 |